Article info

PDF

Donepezil for dementia in Parkinson’s disease: a randomised, double blind, placebo controlled, crossover study
  1. Correspondence to:
 Dr B Ravina
 Program Director, Clinical Trials, NINDS, Neuroscience Center Rm 2225, 6001 Executive Blvd, Rockville, MD 20892-9257, USA; ravinabninds.nih.gov
View Full Text

Citation

Ravina B, Putt M, Siderowf A, et al
Donepezil for dementia in Parkinson’s disease: a randomised, double blind, placebo controlled, crossover study

Publication history

  • Received July 26, 2004
  • Accepted December 17, 2004
  • Revised December 9, 2004
  • First published June 16, 2005.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.